What is the share price of Finecure Pharmaceuticals Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Finecure Pharmaceuticals Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Finecure Pharmaceuticals?

The latest standalone P/E ratio of Finecure Pharmaceuticals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Finecure Pharmaceuticals Ltd?

The latest standalone P/B ratio of Finecure Pharmaceuticals Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Finecure Pharmaceuticals Ltd?

The 52-week high of Finecure Pharmaceuticals Ltd is Rs. 0.00 and the 52-week low is Rs. 0.00.

Finecure Pharmaceuticals Ltd Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Finecure Pharmaceuticals Ltd
Brand: Finecure Pharmaceuticals

Finecure Pharmaceuticals Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Finecure Pharma Share Price

Finecure Pharmaceuticals Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Finecure Pharma Share Price

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹10.5

TTM Sales

₹124 Cr.

Book Value per Share

₹62.6

P/E Ratio

0.00

Industry PE

46.5

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

18.33%

Return on Capital Employed (ROCE)

25.74%

Return on Assets (ROA)

13.23%

Operating Profit Margin

16.2%

Net Profit Margin

10.76%

Gross Profit Margin

16.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

7.38%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-0.94%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-3.4%

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

₹67 Cr.

Equity

₹12.7 Cr.

Face Value

₹10

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	30%	32.2%	34.1%	27.7%	37.2%	43%	38.1%	32.7%	25.7%	-
Value Creation Index ⓘ	1.1	1.3	1.4	1.0	1.7	2.1	1.7	1.3	0.8	-
Growth Parameters ⓘ
Sales ⓘ	15	20	31.2	44.8	65.1	87.2	98.6	115	124	124
Sales YoY Gr.	-	33.3%	55.7%	43.8%	45.3%	34%	13.1%	17.1%	7.4%	-
Adj EPS ⓘ	1.9	2.5	3.3	3.5	5.7	8.8	10.7	10.6	10.3	10.5
YoY Gr.	-	30.4%	33.3%	4.8%	62.9%	55.9%	20.7%	-0.6%	-2.7%	-
BVPS (₹) ⓘ	7.8	10.3	13.5	16.8	22.4	30.8	41.4	51.9	62.6	62.6
Adj Net Profit ⓘ	2.4	3.2	4.2	4.4	7.2	11.2	13.6	13.5	13.1	13
Cash Flow from Ops. ⓘ	0	0	0	2.9	7.6	11.7	11	12.9	11.4	-
Debt/CF from Ops. ⓘ	0	0	0	0.2	0	0.1	0.1	0.1	0.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	22.6%	12.4%	7.4%
Adj EPS ⓘ	NA	24.3%	5.3%	-2.7%
BVPSⓘ	NA	30.1%	26.7%	20.7%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	24.5	27.5	27.9	22.9	29	33.3	29.5	22.7	18	16.8
Op. Profit Mgn % ⓘ	22.5	20.8	17.7	12.5	14.4	16.8	18.7	17.5	16.2	NAN
Net Profit Mgn % ⓘ	16.2	15.8	13.5	9.9	11.1	12.9	13.8	11.7	10.6	10.8
Debt to Equity ⓘ	0.1	0.1	0.1	0	0	0	0	0	0	-
Working Cap Days ⓘ	0	150	123	117	104	96	97	107	122	0
Cash Conv. Cycle ⓘ	0	69	52	52	44	36	37	28	24	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	15.03	20.03	31.18	44.84	65.13	87.24	98.64	115.46	123.98
Operating Expenses ⓘ +	11.64	15.86	25.66	39.25	55.84	72.61	80.22	95.25	103.96
Manufacturing Costs	0.37	0.58	0.97	1.12	1.42	2.17	1.39	1.74	1.76
Material Costs	7.94	11.07	18.12	30.24	42.79	57.35	61	72.87	79.18
Employee Cost	1.09	1.67	2.59	3.40	4.71	6.22	7.15	9.04	9.66
Other Costs ⓘ	2.24	2.54	3.98	4.49	6.93	6.87	10.69	11.60	13.36
Operating Profit ⓘ	3.38	4.17	5.51	5.59	9.29	14.63	18.41	20.21	20.02
Operating Profit Margin (%)	22.5%	20.8%	17.7%	12.5%	14.3%	16.8%	18.7%	17.5%	16.1%
Other Income ⓘ +	0.38	0.54	0.73	0.92	0.69	1.04	0.52	1.37	0.61
Exceptional Items ⓘ	0	0	0	0	0	0	0	-0.39	0
Interest ⓘ	0.07	0.04	0.07	0.06	0.10	0.10	0.19	0.21	0.16
Depreciation ⓘ	0.58	0.71	0.65	0.89	0.55	0.95	1.06	1.32	1.57
Profit Before Tax ⓘ	3.11	3.96	5.52	5.56	9.33	14.61	17.68	19.67	18.90
Tax ⓘ	0.62	0.79	1.31	1.14	2.09	3.36	4.03	5.86	5.56
Profit After Tax	2.49	3.17	4.21	4.41	7.24	11.26	13.65	13.81	13.34
PAT Margin (%)	16.6%	15.8%	13.5%	9.8%	11.1%	12.9%	13.8%	12.0%	10.8%
Adjusted EPS (₹)	2.0	2.5	3.3	3.5	5.7	8.9	10.7	10.9	10.5
Dividend Payout Ratio (%)	0%	0%	3%	3.60%	2.20%	1.40%	1.20%	11.50%	0%

Valuation of Finecure Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund +	9.93	13.09	17.15	21.38	28.40	39.18	52.64	66.25	79.59
Share Capital ⓘ	1.27	1.27	1.27	1.27	1.27	1.27	1.27	12.71	12.71
Reserves ⓘ	8.66	11.82	15.88	20.11	27.13	37.91	51.37	53.55	66.88
Debt +	0.67	1.10	1.44	0.67	0.26	0.55	0.93	0.78	1.06
Long Term Debt	0	0	0.06	0.01	0.25	0.29	0.93	0.40	0.24
Short Term Debt	0.67	1.10	1.38	0.66	0.01	0.26	0	0.38	0.81
Minority Interest	0	0	0	0	0	0	0	0	0
Trade Payables	1.70	3.89	5.13	7.50	8.73	12.81	9.59	21.71	21.29
Others Liabilities ⓘ	1.22	1.27	1.89	2.40	4.43	5.38	6.56	6.23	4.66
Total Liabilities ⓘ	13.53	19.36	25.61	31.95	41.82	57.92	69.72	94.98	106.60
Fixed Assets
Net Fixed Assets ⓘ +	6	6.62	8.10	8.73	9.70	10.76	16.46	18.42	35.89
Gross Block	7.90	9.24	11.56	13.08	14.61	16.62	23.39	26.67	45.61
Accumulated Depreciation	1.90	2.62	3.46	4.35	4.91	5.87	6.93	8.24	9.72
CWIP ⓘ	0	0	0	0.41	6.73	9.22	15.65	25.63	16.67
Investments ⓘ	0.16	0.16	1.55	1.83	3.01	4.56	4.12	5.44	5.69
Inventories	3.63	4.86	6.29	9.12	10.23	11.46	12.14	16.26	20.25
Trade Receivables	2.46	3.66	4.86	6.79	8.45	13.02	12.71	17.06	15.77
Cash Equivalents	0.18	3.36	4.10	4.09	2.10	7.96	6.51	4.55	5.83
Others Assets ⓘ	1.10	0.70	0.71	0.98	1.59	0.94	2.14	7.62	6.49
Total Assets ⓘ	13.53	19.36	25.61	31.95	41.82	57.92	69.72	94.98	106.60

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ +	2.87	7.59	11.70	11.01	12.86	11.37
PBT ⓘ	5.56	9.33	14.61	17.68	19.67	18.90
Adjustment ⓘ	0.63	0.56	0.58	0.96	1.21	1.60
Changes in Working Capital ⓘ	-1.98	-0.9	-0.58	-3.5	-2.41	-3.05
Tax Paid ⓘ	-1.34	-1.40	-2.91	-4.13	-5.61	-6.08
Cash Flow From Investing Activity ⓘ +	-1.89	-8.81	-5.81	-12.45	-14.27	-10.21
Capex	-1.70	-7.89	-4.42	-13.19	-13.26	-10.08
Net Investments	-0.28	-1.19	-1.55	0	0	0
Others ⓘ	0.08	0.27	0.16	0.74	-1.01	-0.13
Cash Flow From Financing Activity ⓘ +	-0.98	-0.77	-0.04	0	-0.55	0.12
Net Proceeds from Shares ⓘ	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.05	0.20	0.28	0	0	0
Interest Paid ⓘ	-0.06	-0.14	-0.14	-0.19	0	0
Dividend Paid ⓘ	-0.15	-0.16	-0.19	-0.16	-0.19	0
Others ⓘ	-0.72	-0.67	0	0.35	-0.36	0.12
Net Cash Flow ⓘ	-0	-1.99	5.85	-1.44	-1.97	1.28

Financial Ratio

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	25.05	27.5	27.81	22.91	29.08	33.32	29.73	23.29	18.33
ROCE (%)	30.01	32.23	34.12	27.66	37.19	43.02	38.05	32.73	25.74
Asset Turnover Ratio	1.11	1.22	1.39	1.56	1.77	1.75	1.55	1.4	1.23
PAT to CFO Conversion(x)	1.15	2.39	2.78	2.5	1.78	1.01	0	0	0
Working Capital Days
Receivable Days	59.80	55.70	49.80	47.40	42.70	44.90	47.60	47	48.30
Inventory Days	88.10	77.30	65.30	62.70	54.20	45.40	43.70	44.90	53.70
Payable Days	78.20	92.20	90.90	76.30	69.20	68.60	67	78.40	99.10

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Finecure Pharmaceuticals Ltd FAQs

The current trading price of Finecure Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Finecure Pharma stood at ₹0.00 Cr

The latest P/E ratio of Finecure Pharma as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Finecure Pharma as of 31-Dec-1969 is 0.00.

The 52-week high of Finecure Pharma is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Finecure Pharma is ₹124 ( Cr.) .

Data is not available for this company.

No data found

About Finecure Pharmaceuticals Ltd

No data to display

Finecure Pharmaceuticals Ltd

Finecure Pharmaceuticals Ltd

10 Year X-Ray :